Back to 
U.S. Bancorp
U.S. Bancorp
MRKR
Showing 3 of 9 quarters
Position history for U.S. Bancorp's holdings in Marker Therapeutics, Inc.
No. U.S. Bancorp exited its MRKR (Marker Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 839 shares worth $2,609. U.S. Bancorp first reported MRKR in Q1 2023 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2,366
Total Shares Change
-839
Quarter-by-Quarter History